- 2 FDA approved medical devices (burette + autoflush) - Devices already in Concord Hospital + NSW Ambulance - Directors underwrote 30% of raise (contributed $1M+ in a $2.8M rights issue) - Wise Owl Analysts target of 7.2c in ST - Brokers, Analysts and Inventors all took stock over $$$ - Announcements hinted at 'major international interest' - Devices pay for themselves - cost:savings ratio 6:1 - MLA distributor with strong connections in Europe - 4c & 8c options with short expiry